Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1949 1
1950 1
1955 1
1972 1
1973 1
1974 5
1975 34
1976 22
1977 36
1978 55
1979 46
1980 59
1981 57
1982 71
1983 68
1984 49
1985 74
1986 67
1987 34
1988 33
1989 31
1990 31
1991 29
1992 14
1993 23
1994 12
1995 16
1996 18
1997 19
1998 10
1999 13
2000 9
2001 14
2002 11
2003 12
2004 7
2005 8
2006 15
2007 10
2008 5
2009 8
2010 8
2011 11
2012 13
2013 18
2014 8
2015 11
2016 8
2017 10
2018 11
2019 16
2020 16
2021 10
2022 9
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,162 results

Results by year

Filters applied: . Clear all
Page 1
Acebutolol: ten years of experience.
De Bono G, Kaye CM, Roland E, Summers AJ. De Bono G, et al. Am Heart J. 1985 May;109(5 Pt 2):1211-3. doi: 10.1016/0002-8703(85)90712-4. Am Heart J. 1985. PMID: 2859785 Review.
Acebutolol is cardioselective, and clinical use has borne out the low incidence of bronchospasm in patients with impaired lung function. ...A combination of selectivity and ISA may be responsible for the low incidence of tiredness and cold extremities observed with aceb …
Acebutolol is cardioselective, and clinical use has borne out the low incidence of bronchospasm in patients with impaired lung functi …
Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
Singh BN, Thoden WR, Wahl J. Singh BN, et al. Pharmacotherapy. 1986 Mar-Apr;6(2):45-63. doi: 10.1002/j.1875-9114.1986.tb03451.x. Pharmacotherapy. 1986. PMID: 3012486 Review.
Acebutolol is a new hydrophilic, cardioselective beta-adrenergic-blocking agent that possesses partial agonist and membrane-stabilizing activities. ...Controlled clinical trials documented the antianginal actions of oral acebutolol in chronic stable angina pectoris; …
Acebutolol is a new hydrophilic, cardioselective beta-adrenergic-blocking agent that possesses partial agonist and membrane-stabilizi …
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Singh BN, Thoden WR, Ward A. Singh BN, et al. Drugs. 1985 Jun;29(6):531-69. doi: 10.2165/00003495-198529060-00003. Drugs. 1985. PMID: 3891306 Review.
Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity. ...In both angina and arrhythmia, when administered twice daily it has been as effective as standard therapeutic a …
Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membr …
Acebutolol.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1985 Jul 5;27(691):58-60. Med Lett Drugs Ther. 1985. PMID: 3892259 Clinical Trial. No abstract available.
Acebutolol saliva excretion.
Giudicelli JF, Freslon JL, Richer C. Giudicelli JF, et al. Br J Clin Pharmacol. 1979 Oct;8(4):373-5. doi: 10.1111/j.1365-2125.1979.tb04724.x. Br J Clin Pharmacol. 1979. PMID: 41552 Free PMC article. No abstract available.
Effects of acebutolol on the serum lipid profile.
Clucas A, Miller N. Clucas A, et al. Drugs. 1988;36 Suppl 2:41-50. doi: 10.2165/00003495-198800362-00008. Drugs. 1988. PMID: 3063505 Review.
The results indicate that, on average, acebutolol does not have any adverse effects on plasma lipids and may even reduce total and low density lipoprotein (LDL)-cholesterol by 7 and 5%, respectively. In contrast, the other beta-blockers compared under the same conditions ( …
The results indicate that, on average, acebutolol does not have any adverse effects on plasma lipids and may even reduce total and lo …
Acebutolol-induced hypersensitivity pneumonitis.
Akoun GM, Herman DP, Mayaud CM, Perrot JY. Akoun GM, et al. Br Med J (Clin Res Ed). 1983 Jan 22;286(6361):266-7. doi: 10.1136/bmj.286.6361.266-a. Br Med J (Clin Res Ed). 1983. PMID: 6402066 Free PMC article. No abstract available.
Acebutolol in supraventricular arrhythmias.
Aronow WS, Van Camp S, Turbow M, Whittaker K, Lurie M. Aronow WS, et al. Clin Pharmacol Ther. 1979 Feb;25(2):149-53. doi: 10.1002/cpt1979252149. Clin Pharmacol Ther. 1979. PMID: 365429 Clinical Trial.
Frequent premature atrial beats were abolished or reduced by greater than 75% in each of 2 patients by acebutolol and not in a patient by saline. Acebutolol converted multifocal atrial tachycardia to sinus rhythm in a patient. ...Acebutolol is useful in the t …
Frequent premature atrial beats were abolished or reduced by greater than 75% in each of 2 patients by acebutolol and not in a patien …
Acebutolol pharmacokinetics in renal failure.
Smith RS, Warren DJ, Renwick AG, George CF. Smith RS, et al. Br J Clin Pharmacol. 1983 Sep;16(3):253-8. doi: 10.1111/j.1365-2125.1983.tb02158.x. Br J Clin Pharmacol. 1983. PMID: 6626416 Free PMC article.
Acebutolol was administered orally in a single dose of 200 mg to 17 individuals whose renal function varied markedly. ...It is concluded that renal elimination is the principal route of excretion for diacetolol but not the parent compound, acebutolol....
Acebutolol was administered orally in a single dose of 200 mg to 17 individuals whose renal function varied markedly. ...It is conclu …
1,162 results

Searches related to "acebutolol"